Taiwan strengthens UK links as it adopts HTA approach
This article was originally published in Scrip
In a sign that Taiwan may be preparing to take on board more ideas from the UK in the areas of drug regulation and possibly health technology assessment, the East Asian island's Food and Drug Administration has signed a formal memorandum of co-operation with the UK Medicines and Healthcare Products Regulatory Agency (MHRA).
You may also be interested in...
Partners say they are encouraged by new overall response data from early trials for the two drugs together in kidney and liver cancer, presented to ASCO.
Focused on precision medicine for renal disease, Chinook gets Aduro’s Nasdaq listing and starting capital of $200m. During a wave of modest-sized M&A deals, Tetra finds buyer, Tetraphase gets competing bids.
Takeda is confident about the promise of its first-in-class molecule for higher-risk myelodysplastic syndromes after positive Phase II data.